Image of Illuminant team at Mount Sinai HospitalImage of Illuminant team at Mount Sinai Hospital
Back arrow
back

Illuminant Demos to Mount Sinai Neurosurgery

October 2, 2023

Our team traveled to New York City to demo our product to the Mount Sinai Health System Department of Neurosurgery, including Chairman Joshua Bederson, Vice-Chair J Mocco, Director of Neurosurgery Spine Tanvir Choudhri, Director of Neurointerventional Spine Reade De Leacy, and Director of Minimally Invasive Spine Surgery Jeremy Steinberger. We are excited to have the opportunity to show our platform to forward-looking surgeons who have a similar vision for 3D navigation.

Illuminant overhead equipmentIlluminant overhead equipment

Illuminant allows you to see everything you need to deliver the highest-quality surgical procedures all in one place, in real time.

Our Technology

Similar Articles

Blog

Illuminant Showcases Work to Johnson & Johnson

Ikaasa Suri, our Chief Clinical Officer, had the opportunity to showcase our work to the Ethicon, Inc. team at Johnson & Johnson.

Blog

Illuminant Begins First In-Human Study at Mount Sinai Hospital

Illuminant began its first-in-human study at Mount Sinai Health System Hospital in New York City.

News

Illuminant Awarded Federal Grant from National Science Foundation

We are excited to announce that we have been awarded a federal grant from the National Science Foundation (NSF). This non-dilutive Phase 1 grant will provide funding to further develop and validate our technology’s application in spine surgery.

Contact Us

Reach out to us to get a closer look at the future of surgical navigation

founders@illuminant.ai
5855 Green Valley Circle
Culver City, CA
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2023 Illuminant. All rights reserved.
Privacy PolicyTerms of Service

The Illuminant Surgical Navigation System is being designed with the intent to improve surgery. All information on this website represents the design goals of Illuminant Surgical and has not been evaluated by the United States Food and Drug Administration (FDA). The product has not been cleared by the FDA and is not for commercial sale in the United States.